vs
NEUROCRINE BIOSCIENCES INC（NBIX）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
NEUROCRINE BIOSCIENCES INC的季度营收约是RANGE RESOURCES CORP的1.0倍（$805.5M vs $786.9M），RANGE RESOURCES CORP净利率更高（22.8% vs 19.1%，领先3.7%），NEUROCRINE BIOSCIENCES INC同比增速更快（28.3% vs 18.0%），过去两年NEUROCRINE BIOSCIENCES INC的营收复合增速更高（25.0% vs 14.6%）
Neurocrine Biosciences是1992年成立的美国生物制药企业，总部位于加利福尼亚州圣地亚哥，截至2024年10月首席执行官为Kyle Gano。公司专注于神经及内分泌相关疾病的疗法研发，旗下药物缬苯那嗪（商品名Ingrezza）于2017年获美国批准，用于治疗成人迟发性运动障碍。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
NBIX vs RRC — 直观对比
营收规模更大
NBIX
是对方的1.0倍
$786.9M
营收增速更快
NBIX
高出10.3%
18.0%
净利率更高
RRC
高出3.7%
19.1%
两年增速更快
NBIX
近两年复合增速
14.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $805.5M | $786.9M |
| 净利润 | $153.7M | $179.1M |
| 毛利率 | 97.8% | 94.5% |
| 营业利润率 | 26.2% | — |
| 净利率 | 19.1% | 22.8% |
| 营收同比 | 28.3% | 18.0% |
| 净利润同比 | 49.1% | 88.8% |
| 每股收益（稀释后） | $1.49 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NBIXRRC
| Q4 25 | $805.5M | $786.9M | ||
| Q3 25 | $794.9M | $655.3M | ||
| Q2 25 | $687.5M | $699.6M | ||
| Q1 25 | $572.6M | $846.3M | ||
| Q4 24 | $627.7M | $667.0M | ||
| Q3 24 | $622.1M | $567.9M | ||
| Q2 24 | $590.2M | $513.2M | ||
| Q1 24 | $515.3M | $598.8M |
净利润NBIXRRC
| Q4 25 | $153.7M | $179.1M | ||
| Q3 25 | $209.5M | $144.3M | ||
| Q2 25 | $107.5M | $237.6M | ||
| Q1 25 | $7.9M | $97.1M | ||
| Q4 24 | $103.1M | $94.8M | ||
| Q3 24 | $129.8M | $50.7M | ||
| Q2 24 | $65.0M | $28.7M | ||
| Q1 24 | $43.4M | $92.1M |
毛利率NBIXRRC
| Q4 25 | 97.8% | 94.5% | ||
| Q3 25 | 98.2% | 92.5% | ||
| Q2 25 | 98.4% | 95.0% | ||
| Q1 25 | 98.4% | 93.1% | ||
| Q4 24 | 98.5% | 93.7% | ||
| Q3 24 | 98.7% | 94.3% | ||
| Q2 24 | 98.4% | 93.4% | ||
| Q1 24 | 98.5% | 94.7% |
营业利润率NBIXRRC
| Q4 25 | 26.2% | — | ||
| Q3 25 | 30.1% | — | ||
| Q2 25 | 21.2% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 29.5% | — | ||
| Q2 24 | 24.6% | — | ||
| Q1 24 | 19.3% | — |
净利率NBIXRRC
| Q4 25 | 19.1% | 22.8% | ||
| Q3 25 | 26.4% | 22.0% | ||
| Q2 25 | 15.6% | 34.0% | ||
| Q1 25 | 1.4% | 11.5% | ||
| Q4 24 | 16.4% | 14.2% | ||
| Q3 24 | 20.9% | 8.9% | ||
| Q2 24 | 11.0% | 5.6% | ||
| Q1 24 | 8.4% | 15.4% |
每股收益（稀释后）NBIXRRC
| Q4 25 | $1.49 | $0.75 | ||
| Q3 25 | $2.04 | $0.60 | ||
| Q2 25 | $1.06 | $0.99 | ||
| Q1 25 | $0.08 | $0.40 | ||
| Q4 24 | $1.00 | $0.38 | ||
| Q3 24 | $1.24 | $0.21 | ||
| Q2 24 | $0.63 | $0.12 | ||
| Q1 24 | $0.42 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $713.0M | $204.0K |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $3.3B | $4.3B |
| 总资产 | $4.6B | $7.4B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资NBIXRRC
| Q4 25 | $713.0M | $204.0K | ||
| Q3 25 | $340.2M | $175.0K | ||
| Q2 25 | $264.0M | $134.0K | ||
| Q1 25 | $194.1M | $344.6M | ||
| Q4 24 | $233.0M | $304.5M | ||
| Q3 24 | $349.1M | $277.4M | ||
| Q2 24 | $139.7M | $251.1M | ||
| Q1 24 | $396.3M | $343.1M |
总债务NBIXRRC
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益NBIXRRC
| Q4 25 | $3.3B | $4.3B | ||
| Q3 25 | $3.0B | $4.2B | ||
| Q2 25 | $2.7B | $4.1B | ||
| Q1 25 | $2.5B | $3.9B | ||
| Q4 24 | $2.6B | $3.9B | ||
| Q3 24 | $2.7B | $3.9B | ||
| Q2 24 | $2.5B | $3.9B | ||
| Q1 24 | $2.4B | $3.8B |
总资产NBIXRRC
| Q4 25 | $4.6B | $7.4B | ||
| Q3 25 | $4.3B | $7.2B | ||
| Q2 25 | $3.9B | $7.1B | ||
| Q1 25 | $3.7B | $7.4B | ||
| Q4 24 | $3.7B | $7.3B | ||
| Q3 24 | $3.5B | $7.2B | ||
| Q2 24 | $3.3B | $7.3B | ||
| Q1 24 | $3.5B | $7.4B |
负债/权益比NBIXRRC
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $388.4M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $386.0M | — |
| 自由现金流率自由现金流/营收 | 47.9% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | 2.53× | 1.44× |
| 过去12个月自由现金流最近4个季度 | $743.9M | — |
8季度趋势，按日历期对齐
经营现金流NBIXRRC
| Q4 25 | $388.4M | $257.5M | ||
| Q3 25 | $227.5M | $247.5M | ||
| Q2 25 | $102.0M | $336.2M | ||
| Q1 25 | $64.8M | $330.1M | ||
| Q4 24 | $242.5M | $217.9M | ||
| Q3 24 | $158.0M | $245.9M | ||
| Q2 24 | $64.6M | $148.8M | ||
| Q1 24 | $130.3M | $331.9M |
自由现金流NBIXRRC
| Q4 25 | $386.0M | — | ||
| Q3 25 | $214.3M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $54.1M | — | ||
| Q4 24 | $235.2M | — | ||
| Q3 24 | $149.9M | — | ||
| Q2 24 | $53.0M | — | ||
| Q1 24 | $119.1M | — |
自由现金流率NBIXRRC
| Q4 25 | 47.9% | — | ||
| Q3 25 | 27.0% | — | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 9.4% | — | ||
| Q4 24 | 37.5% | — | ||
| Q3 24 | 24.1% | — | ||
| Q2 24 | 9.0% | — | ||
| Q1 24 | 23.1% | — |
资本支出强度NBIXRRC
| Q4 25 | 0.3% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 2.2% | — |
现金转化率NBIXRRC
| Q4 25 | 2.53× | 1.44× | ||
| Q3 25 | 1.09× | 1.72× | ||
| Q2 25 | 0.95× | 1.42× | ||
| Q1 25 | 8.20× | 3.40× | ||
| Q4 24 | 2.35× | 2.30× | ||
| Q3 24 | 1.22× | 4.85× | ||
| Q2 24 | 0.99× | 5.18× | ||
| Q1 24 | 3.00× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NBIX
| INGREZZA Net Product Sales | $653.8M | 81% |
| CRENESSITY Net Product Sales | $135.4M | 17% |
| Other Income | $12.6M | 2% |
| Collaboration Revenue | $7.2M | 1% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
